| 0 |
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME |
3 |
0.7500 |
| 1 |
HUMAN ANTI-HUMAN ANTIBODY TEST |
14 |
0.5185 |
| 2 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
134 |
0.3988 |
| 3 |
SYNOVIAL FLUID CRYSTAL |
2 |
0.2500 |
| 4 |
BODY HEIGHT BELOW NORMAL |
132 |
0.2053 |
| 5 |
SHORT STATURE |
38 |
0.1450 |
| 6 |
BONE DENSITY INCREASED |
40 |
0.1003 |
| 7 |
DRUG SPECIFIC ANTIBODY |
111 |
0.0810 |
| 8 |
JUVENILE IDIOPATHIC ARTHRITIS |
139 |
0.0568 |
| 9 |
ANTIBODY TEST POSITIVE |
93 |
0.0560 |
| 10 |
CREUTZFELDT-JAKOB DISEASE |
11 |
0.0381 |
| 11 |
ARTERIAL BRUIT |
1 |
0.0345 |
| 12 |
JOINT DESTRUCTION |
45 |
0.0289 |
| 13 |
DIVERTICULAR FISTULA |
1 |
0.0278 |
| 14 |
POLYARTHRITIS |
139 |
0.0263 |
| 15 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
39 |
0.0169 |
| 16 |
WHEELCHAIR USER |
69 |
0.0155 |
| 17 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
135 |
0.0122 |
| 18 |
ADRENAL INSUFFICIENCY |
142 |
0.0117 |
| 19 |
JUVENILE ARTHRITIS |
3 |
0.0091 |
| 20 |
PERINEAL ABSCESS |
4 |
0.0089 |
| 21 |
OBESITY |
139 |
0.0087 |
| 22 |
JOINT EFFUSION |
59 |
0.0085 |
| 23 |
SYNOVITIS |
138 |
0.0076 |
| 24 |
PROTEIN-LOSING GASTROENTEROPATHY |
3 |
0.0060 |
| 25 |
C-REACTIVE PROTEIN ABNORMAL |
33 |
0.0051 |
| 26 |
OSTEOCHONDROSIS |
5 |
0.0043 |
| 27 |
BONE DENSITY DECREASED |
133 |
0.0042 |
| 28 |
BRONCHOSCOPY |
1 |
0.0042 |
| 29 |
INJECTION SITE NERVE DAMAGE |
1 |
0.0042 |
| 30 |
VESICAL FISTULA |
1 |
0.0040 |
| 31 |
C-REACTIVE PROTEIN INCREASED |
140 |
0.0038 |
| 32 |
RED BLOOD CELL SEDIMENTATION RATE DECREASED |
1 |
0.0038 |
| 33 |
THROMBOCYTOPENIC PURPURA |
5 |
0.0037 |
| 34 |
IMMUNODEFICIENCY |
53 |
0.0036 |
| 35 |
TRANSIENT ACANTHOLYTIC DERMATOSIS |
1 |
0.0034 |
| 36 |
QUALITY OF LIFE DECREASED |
43 |
0.0032 |
| 37 |
SEPTIC SHOCK |
139 |
0.0032 |
| 38 |
MYCOBACTERIUM MARINUM INFECTION |
1 |
0.0031 |
| 39 |
GASTROENTERITIS VIRAL |
53 |
0.0029 |
| 40 |
HYPOCALCAEMIA |
53 |
0.0028 |
| 41 |
TINEA VERSICOLOUR |
1 |
0.0028 |
| 42 |
JOINT INJURY |
59 |
0.0028 |
| 43 |
BONE DENSITY ABNORMAL |
10 |
0.0027 |
| 44 |
STOOL ANALYSIS ABNORMAL |
1 |
0.0026 |
| 45 |
PHYSICAL EXAMINATION ABNORMAL |
1 |
0.0026 |
| 46 |
TOPICAL STEROID WITHDRAWAL REACTION |
1 |
0.0026 |
| 47 |
CONTRAINDICATED PRODUCT ADMINISTERED |
70 |
0.0023 |
| 48 |
DRUG SPECIFIC ANTIBODY PRESENT |
15 |
0.0023 |
| 49 |
IRIDOCYCLITIS |
7 |
0.0022 |
| 50 |
ARTHROPATHY |
123 |
0.0022 |
| 51 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
95 |
0.0020 |
| 52 |
OCCULT BLOOD |
1 |
0.0019 |
| 53 |
PRESCRIBED UNDERDOSE |
38 |
0.0019 |
| 54 |
MOBILITY DECREASED |
135 |
0.0019 |
| 55 |
INTERTRIGO |
1 |
0.0018 |
| 56 |
LIVER FUNCTION TEST ABNORMAL |
52 |
0.0018 |
| 57 |
PITTING OEDEMA |
1 |
0.0016 |
| 58 |
ARTHRITIS REACTIVE |
1 |
0.0016 |
| 59 |
ARTHRITIS |
121 |
0.0015 |
| 60 |
IMPAIRED QUALITY OF LIFE |
22 |
0.0015 |
| 61 |
DRUG INTOLERANCE |
145 |
0.0015 |
| 62 |
VASCULAR PURPURA |
2 |
0.0014 |
| 63 |
THERAPY NON-RESPONDER |
55 |
0.0012 |
| 64 |
INTENTIONAL DEVICE USE ISSUE |
1 |
0.0012 |
| 65 |
HYPOKALAEMIA |
53 |
0.0011 |
| 66 |
STEROID DEPENDENCE |
1 |
0.0011 |
| 67 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 68 |
VAGINAL INFECTION |
5 |
0.0011 |
| 69 |
PSORIASIS |
137 |
0.0010 |
| 70 |
ARTHRODESIS |
1 |
0.0010 |
| 71 |
FACTOR VIII INHIBITION |
1 |
0.0010 |
| 72 |
INNER EAR DISORDER |
1 |
0.0009 |
| 73 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
40 |
0.0009 |
| 74 |
PLEURAL EFFUSION |
53 |
0.0009 |
| 75 |
PRIAPISM |
3 |
0.0009 |
| 76 |
CHRONIC SPONTANEOUS URTICARIA |
1 |
0.0009 |
| 77 |
DILATATION ATRIAL |
1 |
0.0009 |
| 78 |
HYPERTENSIVE EMERGENCY |
1 |
0.0008 |
| 79 |
MALLORY-WEISS SYNDROME |
1 |
0.0008 |
| 80 |
ASPERGILLOSIS |
1 |
0.0008 |
| 81 |
PULMONARY VALVE INCOMPETENCE |
1 |
0.0007 |
| 82 |
UNDERDOSE |
46 |
0.0006 |
| 83 |
INTENTIONAL PRODUCT USE ISSUE |
51 |
0.0006 |
| 84 |
JOINT ARTHROPLASTY |
1 |
0.0006 |
| 85 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 86 |
IRON DEFICIENCY ANAEMIA |
5 |
0.0005 |
| 87 |
BLADDER SPASM |
1 |
0.0005 |
| 88 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 89 |
UVEITIS |
7 |
0.0005 |
| 90 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 91 |
OCCULT BLOOD POSITIVE |
1 |
0.0005 |
| 92 |
ARTHRITIS BACTERIAL |
2 |
0.0005 |
| 93 |
CONDITION AGGRAVATED |
143 |
0.0005 |
| 94 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 95 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 96 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 97 |
LOSS OF CONSCIOUSNESS |
50 |
0.0004 |
| 98 |
RHEUMATOID ARTHRITIS |
42 |
0.0004 |
| 99 |
GROWTH RETARDATION |
1 |
0.0003 |
| 100 |
DIASTOLIC DYSFUNCTION |
1 |
0.0003 |
| 101 |
PANCREATIC CARCINOMA STAGE IV |
1 |
0.0003 |
| 102 |
VOMITING |
137 |
0.0003 |
| 103 |
MICTURITION DISORDER |
1 |
0.0003 |
| 104 |
SKIN WEEPING |
1 |
0.0003 |
| 105 |
DIZZINESS |
138 |
0.0003 |
| 106 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 107 |
PRODUCT USE IN UNAPPROVED INDICATION |
62 |
0.0002 |
| 108 |
HYPOTENSION |
50 |
0.0002 |
| 109 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 110 |
PRODUCT USE ISSUE |
45 |
0.0002 |
| 111 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 112 |
ABSCESS LIMB |
1 |
0.0002 |
| 113 |
CARDIAC MURMUR |
2 |
0.0002 |
| 114 |
IRON DEFICIENCY |
1 |
0.0002 |
| 115 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 116 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 117 |
ROSACEA |
1 |
0.0002 |
| 118 |
DIARRHOEA |
137 |
0.0002 |
| 119 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 120 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 121 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 122 |
NAUSEA |
147 |
0.0002 |
| 123 |
SKIN ATROPHY |
1 |
0.0002 |
| 124 |
ENDOPHTHALMITIS |
1 |
0.0002 |
| 125 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 126 |
PYREXIA |
54 |
0.0002 |
| 127 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 128 |
PAPULE |
1 |
0.0001 |
| 129 |
FAECES DISCOLOURED |
3 |
0.0001 |
| 130 |
ARTHROPOD BITE |
1 |
0.0001 |
| 131 |
ALANINE AMINOTRANSFERASE INCREASED |
8 |
0.0001 |
| 132 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 133 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
9 |
0.0001 |
| 134 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 135 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 136 |
SKIN PLAQUE |
1 |
0.0001 |
| 137 |
ARTHRALGIA |
49 |
0.0001 |
| 138 |
DRUG INEFFECTIVE |
155 |
0.0001 |
| 139 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 140 |
PYELONEPHRITIS |
1 |
0.0001 |
| 141 |
SKIN SWELLING |
1 |
0.0001 |
| 142 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 143 |
HAEMARTHROSIS |
1 |
0.0001 |
| 144 |
BONE DISORDER |
2 |
0.0001 |
| 145 |
DEEP VEIN THROMBOSIS |
7 |
0.0001 |
| 146 |
ASCITES |
3 |
0.0001 |
| 147 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 148 |
OFF LABEL USE |
87 |
0.0001 |
| 149 |
FOLLICULITIS |
1 |
0.0001 |
| 150 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 151 |
RENAL FAILURE ACUTE |
4 |
0.0001 |
| 152 |
REBOUND EFFECT |
1 |
0.0001 |
| 153 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 154 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 155 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 156 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 157 |
MYOCLONUS |
1 |
0.0001 |
| 158 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 159 |
PHARYNGITIS |
1 |
0.0001 |
| 160 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 161 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 162 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 163 |
PALLOR |
2 |
0.0001 |
| 164 |
PARALYSIS |
1 |
0.0001 |
| 165 |
ANOSMIA |
1 |
0.0001 |
| 166 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 167 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 168 |
LUNG INFECTION |
1 |
0.0001 |
| 169 |
ULCER |
1 |
0.0001 |
| 170 |
IMPAIRED HEALING |
2 |
0.0001 |
| 171 |
FACE OEDEMA |
1 |
0.0001 |
| 172 |
CANDIDA INFECTION |
1 |
0.0001 |
| 173 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 174 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 175 |
THIRST |
1 |
0.0001 |
| 176 |
OSTEOMYELITIS |
1 |
0.0001 |
| 177 |
PHOTOPHOBIA |
1 |
0.0001 |
| 178 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 179 |
ORAL HERPES |
1 |
0.0001 |
| 180 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 181 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 182 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 183 |
MOUTH ULCERATION |
1 |
0.0000 |
| 184 |
ADVERSE EVENT |
4 |
0.0000 |
| 185 |
LOCALISED INFECTION |
1 |
0.0000 |
| 186 |
AGEUSIA |
1 |
0.0000 |
| 187 |
ECZEMA |
2 |
0.0000 |
| 188 |
GASTRITIS |
1 |
0.0000 |
| 189 |
PAIN OF SKIN |
1 |
0.0000 |
| 190 |
OEDEMA |
2 |
0.0000 |
| 191 |
SKIN LESION |
1 |
0.0000 |
| 192 |
DIVERTICULITIS |
1 |
0.0000 |
| 193 |
WOUND |
1 |
0.0000 |
| 194 |
TACHYCARDIA |
3 |
0.0000 |
| 195 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 196 |
JOINT SWELLING |
4 |
0.0000 |
| 197 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 198 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 199 |
MOOD SWINGS |
1 |
0.0000 |
| 200 |
FLUSHING |
3 |
0.0000 |
| 201 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 202 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 203 |
EYE SWELLING |
1 |
0.0000 |
| 204 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 205 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 206 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 207 |
MENTAL DISORDER |
1 |
0.0000 |
| 208 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 209 |
HEART RATE INCREASED |
2 |
0.0000 |
| 210 |
PANCREATITIS |
1 |
0.0000 |
| 211 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 212 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 213 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 214 |
WEIGHT INCREASED |
4 |
0.0000 |
| 215 |
EYE IRRITATION |
1 |
0.0000 |
| 216 |
STOMATITIS |
1 |
0.0000 |
| 217 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 218 |
DISCOMFORT |
1 |
0.0000 |
| 219 |
RHINORRHOEA |
1 |
0.0000 |
| 220 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 221 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 222 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 223 |
SLEEP DISORDER |
1 |
0.0000 |
| 224 |
HYPOAESTHESIA |
2 |
0.0000 |
| 225 |
HOSPITALISATION |
2 |
0.0000 |
| 226 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 227 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 228 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 229 |
URTICARIA |
2 |
0.0000 |
| 230 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 231 |
PAIN |
7 |
0.0000 |
| 232 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 233 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 234 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 235 |
WEIGHT DECREASED |
3 |
0.0000 |
| 236 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 237 |
CONTUSION |
1 |
0.0000 |
| 238 |
SYNCOPE |
1 |
0.0000 |
| 239 |
ERYTHEMA |
2 |
0.0000 |
| 240 |
HAEMORRHAGE |
1 |
0.0000 |
| 241 |
SEPSIS |
1 |
0.0000 |
| 242 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 243 |
PRURITUS |
3 |
0.0000 |
| 244 |
HYPERHIDROSIS |
1 |
0.0000 |
| 245 |
DEHYDRATION |
1 |
0.0000 |
| 246 |
VISION BLURRED |
1 |
0.0000 |
| 247 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 248 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 249 |
PARAESTHESIA |
1 |
0.0000 |
| 250 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 251 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 252 |
ANAEMIA |
1 |
0.0000 |
| 253 |
ALOPECIA |
1 |
0.0000 |
| 254 |
HEADACHE |
3 |
0.0000 |
| 255 |
OVERDOSE |
1 |
0.0000 |
| 256 |
DEPRESSION |
1 |
0.0000 |
| 257 |
COUGH |
1 |
0.0000 |
| 258 |
DYSPNOEA |
2 |
0.0000 |
| 259 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 260 |
PNEUMONIA |
1 |
0.0000 |
| 261 |
FATIGUE |
2 |
0.0000 |
| 262 |
MALAISE |
1 |
0.0000 |